Overview of Basic Immunology and Translational Relevance for Clinical Investigators

被引:7
作者
Stephen, Bettzy [1 ]
Hajjar, Joud [2 ,3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Houston, TX 77030 USA
来源
IMMUNOTHERAPY, 2ND EDITION | 2018年 / 995卷
关键词
Adaptive; Biomarkers; CTLA-4; Immune checkpoints; Immunology; Immunotherapy; Innate; PD-1; PD-L1; Resistance; Response; T cells; Translational; REGULATORY T-CELLS; TUMOR-ASSOCIATED MACROPHAGES; ADVANCED MELANOMA PATIENTS; BREAST-CANCER CELLS; MAST-CELLS; SIGNALING PATHWAYS; PERIPHERAL-BLOOD; INNATE IMMUNITY; PD-1; BLOCKADE; HEPATOCELLULAR-CARCINOMA;
D O I
10.1007/978-3-030-02505-2_1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor exists as a complex network of structures with an ability to evolve and evade the host immune surveillance mechanism. The immune milieu which includes macrophages, dendritic cells, natural killer cells, neutrophils, mast cells, B cells, and T cells are found in the core, the invasive margin, or the adjacent stromal or lymphoid component of the tumor. The immune infiltrate is heterogeneous and varies within a patient and between patients of the same tumor histology. The location, density, functionality, and the crosstalk between the immune cells in the tumor microenvironment influence the nature of immune response, prognosis, and treatment outcomes in cancer patients. Therefore, an understanding of the characteristics of the immune cells and their role in tumor immune surveillance is of paramount importance to identify immune targets and to develop novel immune therapeutics in the war against cancer. In this chapter we provide an overview of the individual components of the human immune system and the translational relevance of predictive biomarkers.
引用
收藏
页码:1 / 41
页数:41
相关论文
共 240 条
  • [1] A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
    Acharyya, Swarnali
    Oskarsson, Thordur
    Vanharanta, Sakari
    Malladi, Srinivas
    Kim, Juliet
    Morris, Patrick G.
    Manova-Todorova, Katia
    Leversha, Margaret
    Hogg, Nancy
    Seshan, Venkatraman E.
    Norton, Larry
    Brogi, Edi
    Massague, Joan
    [J]. CELL, 2012, 150 (01) : 165 - 178
  • [2] NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity
    Albertsson, PA
    Basse, PH
    Hokland, M
    Goldfarb, RH
    Nagelkerke, JF
    Nannmark, U
    Kuppen, PJK
    [J]. TRENDS IN IMMUNOLOGY, 2003, 24 (11) : 603 - 609
  • [3] Signatures of mutational processes in human cancer
    Alexandrov, Ludmil B.
    Nik-Zainal, Serena
    Wedge, David C.
    Aparicio, Samuel A. J. R.
    Behjati, Sam
    Biankin, Andrew V.
    Bignell, Graham R.
    Bolli, Niccolo
    Borg, Ake
    Borresen-Dale, Anne-Lise
    Boyault, Sandrine
    Burkhardt, Birgit
    Butler, Adam P.
    Caldas, Carlos
    Davies, Helen R.
    Desmedt, Christine
    Eils, Roland
    Eyfjord, Jorunn Erla
    Foekens, John A.
    Greaves, Mel
    Hosoda, Fumie
    Hutter, Barbara
    Ilicic, Tomislav
    Imbeaud, Sandrine
    Imielinsk, Marcin
    Jaeger, Natalie
    Jones, David T. W.
    Jones, David
    Knappskog, Stian
    Kool, Marcel
    Lakhani, Sunil R.
    Lopez-Otin, Carlos
    Martin, Sancha
    Munshi, Nikhil C.
    Nakamura, Hiromi
    Northcott, Paul A.
    Pajic, Marina
    Papaemmanuil, Elli
    Paradiso, Angelo
    Pearson, John V.
    Puente, Xose S.
    Raine, Keiran
    Ramakrishna, Manasa
    Richardson, Andrea L.
    Richter, Julia
    Rosenstiel, Philip
    Schlesner, Matthias
    Schumacher, Ton N.
    Span, Paul N.
    Teague, Jon W.
    [J]. NATURE, 2013, 500 (7463) : 415 - +
  • [4] Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
    Anderson, Ana C.
    Joller, Nicole
    Kuchroo, Vijay K.
    [J]. IMMUNITY, 2016, 44 (05) : 989 - 1004
  • [5] [Anonymous], FDA APPR KEYTR ADV N
  • [6] Rationale for anti-OX40 cancer immunotherapy
    Aspeslagh, Sandrine
    Postel-Vinay, Sophie
    Rusakiewicz, Sylvie
    Soria, Jean-Charles
    Zitvogel, Laurence
    Marabelle, Aurelien
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 52 : 50 - 66
  • [7] Ayers M, 2015, J IMMUNOTHER CANCER, V3, P80, DOI DOI 10.1186/2051-1426-3-S2-P80
  • [8] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [9] Natural killer cells in innate immunity and cancer
    Becknell, Brian
    Caligiuri, Michael A.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2008, 31 (08) : 685 - 692
  • [10] The new deal a potentia role for secretec vesicles in innate immunity and tumor progression
    Benito-Martin, Alberto
    Di Giannatale, Angela
    Ceder, Sophia
    Peinado, Hector
    [J]. FRONTIERS IN IMMUNOLOGY, 2015, 6 : 1 - 13